Afimmune

Afimmune Limited (Afimmune) is headquartered in Dublin, Ireland, and is a drug discovery and development company dedicated to researching inflammation in major human organs, including the heart and liver, to improve the quality of life for patients with diseases where existing therapies are ineffective or unsafe. Afimmune has assets at various stages of clinical and preclinical development.